A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016).
Saved in:
| Title: | A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016). |
|---|---|
| Authors: | Guerra A; Research, MSD (UK) Limited, London, UK., Costantino C; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Excellence Specialties, University of Palermo, Palermo, Italy., Martinon-Torres F; Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.; GENVIP Research Group (www.genvip.eu), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain., Westerholt S; Pediatrics, Praxis für Kinder- und Jugendmedizin, Wolfsburg, Germany., Lambeth C; Research, Merck & Co., Inc., Rahway, USA., Chen Z; Research, Merck & Co., Inc., Rahway, USA., Lumley J; Research, Merck & Co., Inc., Rahway, USA., Marcek T; Vaccine, MCM Vaccine B.V, Leiden, Netherlands., Johnson D; Vaccine, Sanofi Vaccines, Swiftwater, USA., Wilck M; Research, Merck & Co., Inc., Rahway, USA. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2310900. Date of Electronic Publication: 2024 Feb 08. |
| Publication Type: | Clinical Trial, Phase IV; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
